4-Hydroxy-N-ethyl-N-isobutyltryptamine (4-HO-EiBT, Eibucin) is a substituted tryptamine derivative which acts as a 5-HT2A receptor agonist, with an EC50 of 27.7 nM and an efficacy of 97.5% (vs 5-HT).[1]
Identifiers | |
---|---|
| |
PubChem CID | |
Chemical and physical data | |
Formula | C16H24N2O |
Molar mass | 260.381 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ WO 2023/115167, Banister S, Jorgensen W, Jinlong T, "Compounds", published 2023-06-29, assigned to Psylo Pty Ltd.